Welcome to the 6th Microbiome Movement - Drug Development Summit
The most comprehensive forum for microbiome drug developers, the Microbiome Movement – Drug Development Summit returns for its sixth iteration!
We will continue to unite forward thinking researchers from the biopharmaceutical and academic communities to pursue the causal role of the microbiome in disease, making this the must attend conference for those translating microbiome science into clinically successful therapeutics.
Although there has been recent late-stage clinical success, there still remains a number of challenges that need to be overcome in order for the potential of this complex science area to be realized. From understanding microbiome functionality, leveraging lessons from clinical development and scaling manufacturing processes, through to utilizing microbiome biomarkers for patient stratification and diagnostics, our discussion will cover the latest scientific findings and industry updates from the end-to-end development of microbiome therapeutics.
The 6th Microbiome Movement – Drug Development Summit will provide the perfect opportunity for a collaborative approach to develop a new generation of microbiome-targeted therapeutics that improves patients lives.
Our 65+ World Class Speakers Include
4 Areas that Define the Drug Development Summit
Understanding Microbiome Function & Pre-Clinical Development
Learn the approaches and platforms being harnessed to identify new therapeutic targets to see how you can incorporate the latest scientific findings into your own product pipeline
Clinical Translation & Manufacturing of Microbiome Therapeutics
Hear from subject experts on the major challenges of translating microbiome products through the clinic in order to learn how you can move your products closer to approval and commercialization
Microbiome Biomarkers, Patient Stratification & Diagnostics
Mine the human microbiome to discover new biomarkers and uncover how biomarkers are being used in clinical development in order to better stratify patients and improve clinical outcomes
Pre-Conference Immune-Disease Focus Day
Explore the latest science understanding the causal role of the microbiome in the development of immune-based diseases, to better inform development of candidates focused on IBD and immune-oncology
Hear What the Microbiome Community Says
"The Microbiome Movement – Drug Development Summit is the premier meeting in the microbiome field, and a “must-attend” for those involved in microbiome related drug development”
Blake Wise, Novome Biotechnologies
"This summit offers great opportunity for researchers to share findings and advancements in the microbiome field, and greatly fosters the development of microbiome-based therapeutics and diagnostis”
Xue Liang, Merck Exploratory Science
Confirmed Partners for 2021 Include
Industry Partner:
Lead Partner:
Expertise Partners:
Other Confirmed Partners:
Other Events In The Series
